We are live on ! Find out more
AXSM icon

Axsome Therapeutics
AXSM

260 hedge funds and large institutions have $3.09B invested in Axsome Therapeutics in 2024 Q1 according to their latest regulatory filings, with 45 funds opening new positions, 96 increasing their positions, 75 reducing their positions, and 26 closing their positions.

New
Increased
Maintained
Reduced
Closed

73% more first-time investments, than exits

New positions opened: 45 | Existing positions closed: 26

28% more repeat investments, than reductions

Existing positions increased: 96 | Existing positions reduced: 75

7% more funds holding

Funds holding: 244 → 260 (+16)

1% less capital invested

Capital invested by funds: $3.12B → $3.09B (-$30.4M)

1.03% less ownership

Funds ownership: 82.88% → 81.84% (-1%)

25% less call options, than puts

Call options by funds: $49.5M | Put options by funds: $66.4M

31% less funds holding in top 10

Funds holding in top 10: 13 → 9 (-4)

Holders
260
Holders Change
+16
Holders Change %
+6.56%
% of All Funds
3.75%
Holding in Top 10
9
Holding in Top 10 Change
-4
Holding in Top 10 Change %
-30.77%
% of All Funds
0.13%
New
45
Increased
96
Reduced
75
Closed
26
Calls
$49.5M
Puts
$66.4M
Net Calls
-$16.9M
Net Calls Change
-$54.8M

Top Buyers

1
Macquarie Group
Macquarie Group
Australia
+$56.5M
2
Wellington Management Group
Wellington Management Group
Massachusetts
+$36.7M
3
DTC
Deep Track Capital
Connecticut
+$25.6M
4
Loomis, Sayles & Company
Loomis, Sayles & Company
Massachusetts
+$23.5M
5
EAM
Eagle Asset Management
Florida
+$19M

Top Sellers

1
BI
BVF Inc
California
-$158M
2
Point72 Asset Management
Point72 Asset Management
Connecticut
-$38.5M
3
Pictet Asset Management
Pictet Asset Management
Switzerland
-$29.1M
4
TCM
Tang Capital Management
California
-$25.5M
5
Morgan Stanley
Morgan Stanley
New York
-$24.8M
Name Holding Trade Value Shares
Change 		Change in
Stake
WB
151
WesBanco Bank
West Virginia
$662K +$697K +8,300 New
WS
152
Wedbush Securities
California
$662K -$4.03K -48 -0.6%
OIA
153
OneDigital Investment Advisors
Kansas
$646K +$27.3K +325 +4%
KAS
154
Kestra Advisory Services
Texas
$621K +$142K +1,691 +28%
D.E. Shaw & Co
155
D.E. Shaw & Co
New York
$620K -$119K -1,415 -15%
MA
156
MONECO Advisors
Connecticut
$597K – – –
Canada Life
157
Canada Life
Manitoba, Canada
$588K +$357K +4,258 +137%
GT
158
Glenmede Trust
Pennsylvania
$583K -$5.29K -63 -0.9%
State Board of Administration of Florida Retirement System
159
State Board of Administration of Florida Retirement System
Florida
$581K -$52K -620 -6%
Creative Planning
160
Creative Planning
Kansas
$576K +$30.6K +364 +5%
Rafferty Asset Management
161
Rafferty Asset Management
New York
$548K +$86K +1,025 +18%
Teacher Retirement System of Texas
162
Teacher Retirement System of Texas
Texas
$546K -$28.8K -343 -5%
CIP
163
Chartwell Investment Partners
Pennsylvania
$536K +$563K +6,706 New
TAM
164
Tocqueville Asset Management
New York
$503K -$33.6K -400 -6%
DC
165
Davenport & Co
Virginia
$464K +$168K +2,000 +52%
Janney Montgomery Scott
166
Janney Montgomery Scott
Pennsylvania
$461K +$42K +500 +9%
Cetera Investment Advisers
167
Cetera Investment Advisers
Illinois
$453K +$476K +5,675 New
PNC Financial Services Group
168
PNC Financial Services Group
Pennsylvania
$430K +$4.28K +51 +1%
VEA
169
Virtus ETF Advisers
New York
$415K +$62.8K +748 +17%
Zurich Cantonal Bank
170
Zurich Cantonal Bank
Switzerland
$415K -$53.3K -635 -11%
Victory Capital Management
171
Victory Capital Management
Texas
$407K -$8.56K -102 -2%
YC
172
Yarbrough Capital
Tennessee
$403K +$424K +5,054 New
CCIA
173
Campbell & Co Investment Adviser
Maryland
$389K +$409K +4,869 New
HSBC Holdings
174
HSBC Holdings
United Kingdom
$386K -$6.35M -75,601 -94%
LCM
175
Legato Capital Management
California
$378K -$326K -3,889 -45%
5 6
7
8 9

AXSM Hedge Fund Activity: Q1 2024 in Review

260 of the 6,942 institutional investors tracked by Wall St. Rank reported a position in Axsome Therapeutics (AXSM) for Q1 2024, worth a combined $3.09B — down 0.98% from $3.12B a quarter earlier.

Buyers outnumbered sellers: 45 funds opened new AXSM positions and 26 closed out — a net gain of 19 holders — while 96 added to existing stakes and 75 trimmed.

The largest buyer was Macquarie Group, adding an estimated $56.5M. The largest seller was BVF Inc, exiting entirely with an estimated $158M sold.

  • 260 institutional investors held Axsome Therapeutics (AXSM) as of Q1 2024, up from 244 in Q4 2023.
  • Funds reported $3.09B of Axsome Therapeutics stock for Q1 2024, down 0.98% quarter-over-quarter.
  • 45 funds opened new Axsome Therapeutics positions in Q1 2024 and 26 closed out, a net change of +19 holders.
  • The largest Axsome Therapeutics buyer in Q1 2024 was Macquarie Group, an estimated $56.5M added.
  • The largest Axsome Therapeutics seller in Q1 2024 was BVF Inc, an estimated $158M sold.

Based on aggregated 13F filings for Q1 2024.